Mode
Text Size
Log in / Sign up
Phase 4 Completed N=642 Randomized Treatment

Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS)

Smoking, Tobacco
Source: ClinicalTrials.gov NCT03611881 ↗
Enrolled (actual)
642
Serious AEs
0.0%
Results posted
Jul 2024
Primary outcomePrimary: Number of Participants With Self-reported Past 7-day Smoking Abstinence — 12; 10; 12; 15 Participants
◆ Published Evidence
Emerging
15citations · ~15 / year
Integrating Tobacco Treatment Into Lung Cancer Screening: The Screen Assist Factorial Randomized Clinical Trial.
JAMA internal medicine · 2025 · Open access · Likely link

Summary

This randomized controlled trial seeks to evaluate the effectiveness of alternative strategies to integrate smoking cessation interventions into the delivery of low-dose CT (LDCT) lung cancer screening. Using a factorial design, current smokers who enroll will be randomly assigned to receive these interventions: (1) smoking cessation counseling support by telephone or videoconferencing (short duration vs. long duration); (2) nicotine patch treatment (NRT) (short vs.long duration); (3) counselor-facilitated referral (vs. no referral) to an online resource to connect smokers to a community-based social service resources.

Linked Publications (2)

  • Integrating Tobacco Treatment Into Lung Cancer Screening: The Screen Assist Factorial Randomized Clinical Trial.
    JAMA internal medicine · 2025 · 15 citations · Open access · Likely link
  • Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment.
    JNCI cancer spectrum · 2022 · 6 citations · Open access · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Self-reported Past 7-day Smoking Abstinence
6; 11; 10; 14; 8; 14
SECONDARY
Number of Participants With Self-Reported Past 7-day Smoking Abstinence
6; 11; 10; 14; 8; 14
SECONDARY
Proportion of Participants Who Reduced the Number of Cigarettes Smoked Per Day in Half
21; 23; 23; 26; 19; 21
SECONDARY
Proportion of Patients Who Make an Intentional Attempt to Quit Smoking
37; 40; 33; 44; 36; 38

Eligibility Criteria

Inclusion Criteria

  • Scheduled to undergo LDCT-LCS at a participating Mass General Brigham Health Care System LCS site
  • Speak English or Spanish.
  • Current smokers: smoked a cigarette, even a puff, in the last 30 days.
  • Medicare coverage requirement (age 50-80 years, 20+ pack/years).
  • Residing within the USA.

Exclusion Criteria

  • Undergoing lung CT as part of a diagnostic or abnormal follow-up evaluation.
  • Unable to give informed consent due to psychiatric or cognitive impairment as determined in consultation with study PI or treating clinician.
  • No access to a telephone or cannot communicate by telephone.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03611881) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search